Table 2.
Proficiency panel of viral and bacterial samples tested using the modified CDC SARS-CoV-2 assay.
| Organisms | Source | Method of Identification | Interpretation |
|---|---|---|---|
| MERS CoV | Control Suspension | IDT# 10006623 | Not-Detected |
| SARS CoV | Control Suspension | IDT# 10006624 | Not Detected |
| Adenovirus | Control Suspension | Exact DX# ADVH102 | Not-Detected |
| Coronavirus HKU1 | NP Patient Sample | BioFire RVP2 | Not-Detected |
| Coronavirus NL63 | NP Patient Sample | BioFire RVP2 | Not-Detected |
| Coronavirus 229E | NP Patient Sample | BioFire RVP2 | Not-Detected |
| Coronavirus OC43 | NP Patient Sample | BioFire RVP2 | Not-Detected |
| Influenza A | NP Patient Sample | BioFire RVP2 | Not-Detected |
| Influenza B | NP Patient Sample | BioFire RVP2 | Not-Detected |
| Respiratory Syncytial Virus | NP Patient Sample | BioFire RVP2 | Not-Detected |
| Human Metapneumovirus | NP Patient Sample | BioFire RVP2 | Not-Detected |
| Human Rhinovirus | NP Patient Sample | BioFire RVP2 | Not-Detected |
| Chlamydia pneumoniae | NP Patient Sample | BioFire RVP2 | Not-Detected |
| Mycoplasma pneumoniae | NP Patient Sample | BioFire RVP2 | Not-Detected |
| Parainfluenza Virus 1 | NP Patient Sample | BioFire RVP2 | Not-Detected |
| Parainfluenza Virus 2 | NP Patient Sample | BioFire RVP2 | Not-Detected |
| Parainfluenza Virus 3 | NP Patient Sample | BioFire RVP2 | Not-Detected |
| Parainfluenza Virus 4 | NP Patient Sample | BioFire RVP2 | Not-Detected |
| Staphylococcus epidermidis | 0.5 McFarland Suspension | ATCC Strain 14990 | Not-Detected |
| Streptococcus pyogenes | 0.5 McFarland Suspension | ATCC Strain 19615 | Not-Detected |
| Pseudomonas aeruginosa | 0.5 McFarland Suspension | ATCC Strain 27853 | Not-Detected |
| Mycobacterium tuberculosis | 0.5 McFarland Suspension | ATCC Strain 25177 | Not-Detected |